转移性结直肠癌的新联合治疗方案：我们有哪些期望？ - Suppr

New combinations in metastatic colorectal cancer: what are our expectations?

作者信息

Hurwitz Herbert

机构信息

Duke University Medical Center, Durham, North Carolina 27710, USA.

出版信息

Oncologist. 2005 May;10(5):320-2. doi: 10.1634/theoncologist.10-5-320.

DOI:10.1634/theoncologist.10-5-320

PMID:15851788

Abstract

摘要

相似文献

New combinations in metastatic colorectal cancer: what are our expectations?

Oncologist. 2005 May;10(5):320-2. doi: 10.1634/theoncologist.10-5-320.

[The development of the first line treatment of metastatic colorectal cancer (mCRC)].

Magy Onkol. 2009 Sep;53(3):237-46. doi: 10.1556/MOnkol.53.2009.3.1.

[Metastatic colorectal cancer: adjournments from ESMO 2006].

Tumori. 2006 Nov-Dec;92(6):1-12. doi: 10.1177/030089160609200627.

Dual biologic therapy in the first-line mCRC setting: implications of the CAIRO2 study.

Clin Colorectal Cancer. 2008 Jul;7(4):226. doi: 10.3816/CCC.2008.n.030.

Common side effects and interactions of colorectal cancer therapeutic agents.

J Pract Nurs. 2011 Spring;61(1):7-20.

[Progress of chemotherapy in colorectal cancer].

Gan To Kagaku Ryoho. 2007 Nov;34(11):1771-6.

Short time infusion of bevacizumab in combination with 5FU-based chemotherapy as first-line therapy in a non-selective patient group with metastatic colorectal cancer.

Acta Oncol. 2010 Apr;49(3):395-6. doi: 10.3109/02841860903428184.

Chemotherapy and immunotherapy in metastatic colorectal cancer.

N Engl J Med. 2009 May 14;360(20):2134; author reply 2135-6. doi: 10.1056/NEJMc090489.

[Present status of chemotherapy for colorectal cancer in countries outside of Japan].

Nihon Rinsho. 2003 Sep;61 Suppl 7:368-73.

Cost-effectiveness of targeted therapy with cetuximab in patients with K-ras wild-type colorectal cancer presenting with initially unresectable metastases limited to the liver in a German setting.

Clin Ther. 2011 Apr;33(4):482-97. doi: 10.1016/j.clinthera.2011.04.010.

引用本文的文献

Thromboembolic Events Associated with Bevacizumab plus Chemotherapy for Patients with Colorectal Cancer: A Meta-Analysis of Randomized Controlled Trials.

Am Health Drug Benefits. 2016 Jun;9(4):221-32.

Capecitabine and irinotecan with and without bevacizumab for advanced colorectal cancer patients.

World J Gastroenterol. 2009 Jan 28;15(4):449-56. doi: 10.3748/wjg.15.449.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

New combinations in metastatic colorectal cancer: what are our expectations?

作者信息

机构信息

出版信息

相似文献

引用本文的文献

文献AI研究员

用中文搜PubMed

文档翻译

Suppr 超能文献

New combinations in metastatic colorectal cancer: what are our expectations?

作者信息

机构信息

出版信息

相似文献

引用本文的文献